Found 8 results
Author Title [ Type(Asc)] Year
Filters: Author is Srivastava, S  [Clear All Filters]
Journal Article
R. B. Nussenblatt, Rao, N. A., Foster, C. S., Sen, H. N., Srivastava, S., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Robinson, R. R., Shames, R. S., and Buggage, R. R., Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis, 2003.
R. Buggage, Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., Bamji, A., Waldmann, T., and Nussenblatt, R., A Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease, 2003.
J. N. Leuschen, Schuman, S. G., Winter, K. P., McCall, M. N., Wong, W. T., Chew, E. Y., Hwang, T., Srivastava, S., Sarin, N., Clemons, T., Harrington, M., and Toth, C. A., Spectral-Domain Optical Coherence Tomography Characteristics of Intermediate Age-Related Macular Degeneration, Opthalmology, vol. 120, pp. 140-150, 2013.
R. Buggage, Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., Bamji, A., Waldmann, T., and Nussenblatt, R., A masked randomized study to investigate the safety and efficacy of Daclizumab for treatment of Ocular Behcet’s Disease, 2003.
S. Dahr, Cusic, M., Rodriguez-Coleman, H., Srivastava, S., Thompson, D., Ferris, F., Csaky, K., Linehan, M., and Chew, E., Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina, Retina, vol. 27, pp. 150-158, 2007.
R. B. Nussenblatt, Thompson, D. J. S., Li, Z., Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. T., Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Suhler, E. B., Djalilian, A., Sen, H. N., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Mellow, S., Sran, P., and , Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration, J Autoimmun, vol. 21, pp. 283-293, 2003.
R. Nussenblatt, Li, Z., Robinson, R., Shames, R., Tang, M., Mailman, M., Thompson, D., Peterson, J., Sen, H., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Sran, P., Waldmann, T., and Buggage, R., Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy, 2003.
Conference Paper
M. Cusik, Dahr, S., Srivastava, S., Coleman, H., Thompson, D., and Chew, E., Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease, in Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2004.